Optimer Pharma (OPTR) Names Stephen Webster as CFO
Tweet
Share
E-mailGet Alerts OPTR Hot Sheet
Join SI Premium – FREE
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) has appointed Stephen Webster as Chief Financial Officer. Mr. Webster will be responsible for directing Optimer's financial strategy, accounting and investor relations functions.
Prior to joining Optimer, Mr. Webster served as Chief Financial Officer of Adolor Corporation until its sale to Cubist Pharmaceuticals, Inc.
Prior to joining Optimer, Mr. Webster served as Chief Financial Officer of Adolor Corporation until its sale to Cubist Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JBS names Wesley Batista Filho as global CEO, effective January 2027
- Shoulder Innovations names Jon Osborne as chief commercial officer
- Applied Aerospace & Defense names Chris Rogers president and CSO
Create E-mail Alert Related Categories
Management ChangesRelated Entities
Cubist Pharmaceuticals Inc./Adolor Corp.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
